{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:16:37Z","timestamp":1781100997325,"version":"3.54.1"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.lfs.2020.118883","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T17:10:12Z","timestamp":1607706612000},"page":"118883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-\u03b2 signalling in COVID-19 survivors"],"prefix":"10.1016","volume":"266","author":[{"given":"Krishna Murthy","family":"P","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthikeyan","family":"Sivashanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasekaran","family":"Subbiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilwanathan","family":"Ravikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118883_bb0005","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-020-03899-4","article-title":"The genetic sequence, origin, and diagnosis of SARS-CoV-2","author":"Wang","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"key":"10.1016\/j.lfs.2020.118883_bb0010","series-title":"Cent. Dis. Control Prev","article-title":"Coronavirus disease 2019 (COVID-19)","author":"CDC","year":"2020"},{"key":"10.1016\/j.lfs.2020.118883_bb0015","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2020200463","article-title":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection","volume":"295","author":"Bernheim","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.lfs.2020.118883_bb0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1148\/radiol.2020200274","article-title":"Emerging 2019 novel coronavirus (2019-nCoV) pneumonia","volume":"295","author":"Song","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.lfs.2020.118883_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.139021","article-title":"Follow-up studies in COVID-19 recovered patients - is it mandatory?","volume":"729","author":"Balachandar","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.lfs.2020.118883_bb0030","first-page":"157","article-title":"Clinical characteristics and changes of chest CT features in 307 patients with common COVID-19 pneumonia infected SARS-CoV-2: a multicenter study in Jiangsu, China","volume":"96","author":"Shang","year":"2020","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"10.1016\/j.lfs.2020.118883_bb0035","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2214\/AJR.20.22975","article-title":"CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China","volume":"214","author":"Zhou","year":"2020","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.lfs.2020.118883_bb0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiol.2020200370","article-title":"Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19)","volume":"295","author":"Pan","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.lfs.2020.118883_bb0045","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00247-020-04656-7","article-title":"Chest computed tomography in children with COVID-19 respiratory infection","volume":"50","author":"Li","year":"2020","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.lfs.2020.118883_bb0050","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00259-020-04735-9","article-title":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2","volume":"47","author":"Xu","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.lfs.2020.118883_bb0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3348\/kjr.2020.0132","article-title":"Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): analysis of nine patients treated in Korea","volume":"21","author":"Yoon","year":"2020","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.lfs.2020.118883_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109009","article-title":"Chest CT findings of COVID-19 pneumonia by duration of symptoms","volume":"127","author":"Ding","year":"2020","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.lfs.2020.118883_bb0065","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1007\/s00330-020-06801-0","article-title":"Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review","volume":"30","author":"Ye","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.lfs.2020.118883_bb0070","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-020-06860-3","article-title":"CT features of novel coronavirus pneumonia (COVID-19) in children","author":"Duan","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.lfs.2020.118883_bb0075","article-title":"Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients","author":"Ju","year":"2020","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.lfs.2020.118883_bb0080","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1007\/s00330-020-06731-x","article-title":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China","volume":"30","author":"Pan","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.lfs.2020.118883_bb0085","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","article-title":"Pathology and pathogenesis of severe acute respiratory syndrome","volume":"170","author":"Gu","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2020.118883_bb0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41413-020-0084-5","article-title":"Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study","volume":"8","author":"Zhang","year":"2020","journal-title":"Bone Res"},{"key":"10.1016\/j.lfs.2020.118883_bb0095","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jcp.2003.013276","article-title":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)","volume":"57","author":"Tse","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.lfs.2020.118883_bb0100","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1148\/radiol.2283030726","article-title":"Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience","volume":"228","author":"Antonio","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.lfs.2020.118883_bb0105","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/00004728-200411000-00010","article-title":"Severe acute respiratory syndrome: thin-section computed tomography features, temporal changes, and clinicoradiologic correlation during the convalescent period","volume":"28","author":"Wong","year":"2004","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.lfs.2020.118883_bb0110","first-page":"2793","article-title":"Thin-section computed tomography manifestations during convalescence and long-term follow-up of patients with severe acute respiratory syndrome (SARS)","volume":"22","author":"Wu","year":"2016","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"10.1016\/j.lfs.2020.118883_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2214\/ajr.182.1.1820039","article-title":"High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission","volume":"182","author":"M\u00fcller","year":"2004","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.lfs.2020.118883_bb0120","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2214\/AJR.05.0382","article-title":"Thin-section CT 12 months after the diagnosis of severe acute respiratory syndrome in pediatric patients","volume":"186","author":"Chu","year":"2006","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.lfs.2020.118883_bb0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4103\/ijri.IJRI_469_16","article-title":"Follow-up chest radiographic findings in patients with MERS-CoV after recovery","volume":"27","author":"Das","year":"2017","journal-title":"Indian J Radiol Imaging"},{"key":"10.1016\/j.lfs.2020.118883_bb0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.virol.2007.09.045","article-title":"SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells","volume":"372","author":"Mossel","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.lfs.2020.118883_bb0135","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/infdis\/jis455","article-title":"Influenza A viruses target type II pneumocytes in the human lung","volume":"206","author":"Weinheimer","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118883_bb0140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fcimb.2020.00340","article-title":"SARS-CoV-2 pathogenesis: imbalance in the renin-angiotensin system favors lung fibrosis","volume":"10","author":"Delpino","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2020.118883_bb0145","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biology perspective","volume":"55","author":"Mason","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2020.118883_bb0150","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.lfs.2020.118883_bb0155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41392-020-00355-9","article-title":"Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples","volume":"5","author":"Leng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.lfs.2020.118883_bb0160","first-page":"343","article-title":"Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis","volume":"11","author":"Meyer","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.lfs.2020.118883_bb0165","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.lfs.2020.118883_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-019-0362-3","article-title":"TGF-\u03b2 in fibrosis by acting as a conductor for contractile properties of myofibroblasts","volume":"9","author":"Vall\u00e9e","year":"2019","journal-title":"Cell Biosci"},{"key":"10.1016\/j.lfs.2020.118883_bb0175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2020.118883_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-016-0343-6","article-title":"Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis","volume":"17","author":"Pardo","year":"2016","journal-title":"Respir. Res."},{"key":"10.1016\/j.lfs.2020.118883_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","author":"George","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2020.118883_bb0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12079-020-00569-0","article-title":"COVID-19: is fibrosis the killer?","volume":"14","author":"Leask","year":"2020","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.lfs.2020.118883_bb0195","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.lfs.2020.118883_bb0200","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3348\/kjr.2020.0215","article-title":"Prediction of the development of pulmonary fibrosis using serial thin-section CT and clinical features in patients discharged after treatment for COVID-19 pneumonia","volume":"21","author":"Yu","year":"2020","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.lfs.2020.118883_bb0205","author":"MGH FLARE"},{"key":"10.1016\/j.lfs.2020.118883_bb0210","doi-asserted-by":"crossref","first-page":"6175964","DOI":"10.1155\/2020\/6175964","article-title":"Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies","volume":"2020","author":"Ojo","year":"2020","journal-title":"Pulm Med"},{"key":"10.1016\/j.lfs.2020.118883_bb0215","article-title":"Converging pathways in pulmonary fibrosis and Covid-19 - the fibrotic link to disease severity","volume":"2","author":"Wig\u00e9n","year":"2020","journal-title":"Respir Med X"},{"key":"10.1016\/j.lfs.2020.118883_bb0220","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-015-0261-z","article-title":"Bidirectional role of IL-6 signal in pathogenesis of lung fibrosis","volume":"16","author":"Kobayashi","year":"2015","journal-title":"Respir. Res."},{"key":"10.1016\/j.lfs.2020.118883_bb0225","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.194.6.809","article-title":"Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1)","volume":"194","author":"Lee","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2020.118883_bb0230","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1165\/ajrcmb.17.3.2733","article-title":"Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma","volume":"17","author":"Minshall","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118883_bb0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1165\/ajrcmb.14.2.8630262","article-title":"TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study","volume":"14","author":"Khalil","year":"1996","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118883_bb0240","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/thorax.56.12.907","article-title":"Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis","volume":"56","author":"Khalil","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2020.118883_bb0245","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1016\/S0012-3692(15)38703-1","article-title":"Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?","volume":"120","author":"Roberts","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2020.118883_bb0250","first-page":"816","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"10.1016\/j.lfs.2020.118883_bb0255","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/jcmm.12298","article-title":"TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons","volume":"18","author":"Kandasamy","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2020.118883_bb0260","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.antiviral.2017.03.022","article-title":"The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis","volume":"143","author":"Venkataraman","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.lfs.2020.118883_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127888","article-title":"DA-Raf-mediated suppression of the Ras\u2014ERK pathway is essential for TGF-\u03b21-induced epithelial-mesenchymal transition in alveolar epithelial type 2 cells","volume":"10","author":"Watanabe-Takano","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118883_bb0270","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1074\/jbc.M708033200","article-title":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling","volume":"283","author":"Zhao","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118883_bb0275","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1165\/ajrcmb.21.6.3719","article-title":"Enhanced insulin-like growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis","volume":"21","author":"Allen","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118883_bb0280","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1074\/jbc.M114.606186","article-title":"Myofibroblasts exhibit enhanced fibronectin assembly that is intrinsic to their contractile phenotype","volume":"290","author":"Torr","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118883_bb0285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1083\/jcb.122.1.103","article-title":"Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts","volume":"122","author":"Desmouli\u00e8re","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118883_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041611","article-title":"Fra-1\/AP-1 transcription factor negatively regulates pulmonary fibrosis in vivo","volume":"7","author":"Rajasekaran","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118883_bb0295","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.resp.2013.09.011","article-title":"Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice","volume":"190","author":"Shi","year":"2014","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.lfs.2020.118883_bb0300","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pharep.2016.12.013","article-title":"C-phycocyanin suppresses transforming growth factor-\u03b21-induced epithelial mesenchymal transition in human epithelial cells","volume":"69","author":"Pattarayan","year":"2017","journal-title":"Pharmacol Rep PR"},{"key":"10.1016\/j.lfs.2020.118883_bb0305","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12016-016-8589-9","article-title":"Diagnostic potential of extracellular microRNA in respiratory diseases","volume":"54","author":"Pattarayan","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.lfs.2020.118883_bb0310","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fphar.2015.00254","article-title":"MicroRNAs as potential targets for progressive pulmonary fibrosis","volume":"6","author":"Rajasekaran","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118883_bb0315","article-title":"Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine","volume":"2","author":"Myll\u00e4rniemi","year":"2015","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.lfs.2020.118883_bb0320","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/CE.S76549","article-title":"Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy","volume":"11","author":"Margaritopoulos","year":"2016","journal-title":"Core Evid"},{"key":"10.1016\/j.lfs.2020.118883_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48593-4","article-title":"Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis","volume":"9","author":"Kato","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118883_bb0330","author":"Zhang"},{"key":"10.1016\/j.lfs.2020.118883_bb0335","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1177\/1060028019862497","article-title":"Management of idiopathic pulmonary fibrosis","volume":"53","author":"Pleasants","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.lfs.2020.118883_bb0340","first-page":"651","article-title":"Histone deacetylases as targets for treatment of multiple diseases","volume":"124","author":"Tang","year":"2013","journal-title":"Clin Sci Lond Engl 1979"},{"key":"10.1016\/j.lfs.2020.118883_bb0345","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.bbamcr.2007.05.016","article-title":"Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation","volume":"1773","author":"Glenisson","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2020.118883_bb0350","doi-asserted-by":"crossref","first-page":"L864","DOI":"10.1152\/ajplung.00128.2009","article-title":"Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition","volume":"297","author":"Guo","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.lfs.2020.118883_bb0355","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/thoraxjnl-2014-206411","article-title":"Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis","volume":"70","author":"Korfei","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2020.118883_bb0360","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.matbio.2010.05.002","article-title":"HDAC-mediated control of ERK- and PI3K-dependent TGF-\u03b2-induced extracellular matrix-regulating genes","volume":"29","author":"Barter","year":"2010","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"10.1016\/j.lfs.2020.118883_bb0365","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.233486","article-title":"TGF\u03b2-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression","volume":"132","author":"Jones","year":"2019","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.lfs.2020.118883_bb0370","doi-asserted-by":"crossref","first-page":"L175","DOI":"10.1152\/ajplung.00551.2017","article-title":"HDAC8 inhibition ameliorates pulmonary fibrosis","volume":"316","author":"Saito","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.lfs.2020.118883_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061329","article-title":"HDAC inhibitors: therapeutic potential in fibrosis-associated human diseases","volume":"20","author":"Yoon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2020.118883_bb0380","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1128\/MCB.01776-08","article-title":"Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis","volume":"29","author":"Coward","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2020.118883_bb0385","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1038\/cddis.2013.146","article-title":"Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts","volume":"4","author":"Huang","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2020.118883_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186615","article-title":"Tubastatin ameliorates pulmonary fibrosis by targeting the TGF\u03b2-PI3K-Akt pathway","volume":"12","author":"Saito","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118883_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207915","article-title":"Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis","volume":"13","author":"Korfei","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118883_bb0400","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1183\/09031936.00077309","article-title":"Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology","volume":"35","author":"Vancheri","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2020.118883_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2020.118883_bb0410","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.biopha.2014.01.002","article-title":"Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells","volume":"68","author":"Karthik","year":"2014","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"10.1016\/j.lfs.2020.118883_bb0415","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.biopha.2014.12.023","article-title":"Blocking NF-\u03baB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species","volume":"69","author":"Karthik","year":"2015","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"10.1016\/j.lfs.2020.118883_bb0420","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1148\/radiol.2303030853","article-title":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients","volume":"230","author":"Ooi","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.lfs.2020.118883_bb0425","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1378\/chest.126.1.149","article-title":"Correlation of high-resolution CT, symptoms, and pulmonary function in patients during recovery from severe acute respiratory syndrome","volume":"126","author":"Hsu","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2020.118883_bb0430","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1148\/radiol.2363040958","article-title":"Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT","volume":"236","author":"Chang","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.lfs.2020.118883_bb0435","first-page":"512","article-title":"Thoracic high resolution CT findings of 100 SARS patients in convalescent period","volume":"25","author":"Jin","year":"2003","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.lfs.2020.118883_bb0440","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/thx.2004.023762","article-title":"Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors","volume":"59","author":"Ng","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2020.118883_bb0445","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ppul.20078","article-title":"Radiological and pulmonary function outcomes of children with SARS","volume":"38","author":"Li","year":"2004","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.lfs.2020.118883_bb0450","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-6-5","article-title":"Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge","volume":"6","author":"Xie","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.lfs.2020.118883_bb0455","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1148\/radiol.2303030894","article-title":"Late-stage adult respiratory distress syndrome caused by severe acute respiratory syndrome: abnormal findings at thin-section CT","volume":"230","author":"Joynt","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.lfs.2020.118883_bb0460","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1183\/09031936.00084808","article-title":"Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?","volume":"34","author":"Wang","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2020.118883_bb0465","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1165\/rcmb.2010-0154OC","article-title":"Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts","volume":"45","author":"Sanders","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118883_bb0470","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbagrm.2018.03.007","article-title":"Suberanilohydroxamic acid prevents TGF-\u03b21-induced COX-2 repression in human lung fibroblasts post-transcriptionally by TIA-1 downregulation","volume":"1861","author":"Pasini","year":"2018","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"10.1016\/j.lfs.2020.118883_bb0475","doi-asserted-by":"crossref","first-page":"19605","DOI":"10.3390\/ijms141019605","article-title":"Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts","volume":"14","author":"Zhang","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2020.118883_bb0480","doi-asserted-by":"crossref","first-page":"48737","DOI":"10.18632\/oncotarget.17114","article-title":"The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis","volume":"8","author":"Conforti","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118883_bb0485","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/01902148.2015.1060275","article-title":"Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo","volume":"41","author":"Ota","year":"2015","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.lfs.2020.118883_bb0490","first-page":"219","article-title":"Prevention of pulmonary fibrosis via trichostatin A (TSA) in bleomycin induced rats","volume":"31","author":"Ye","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"key":"10.1016\/j.lfs.2020.118883_bb0495","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1165\/rcmb.2011-0040OC","article-title":"Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis","volume":"46","author":"Davies","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520316362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520316362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:21:55Z","timestamp":1758986515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520316362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":99,"alternative-id":["S0024320520316362"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118883","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-\u03b2 signalling in COVID-19 survivors","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118883"}}